Ignite Creation Date:
2024-05-05 @ 10:00 AM
Last Modification Date:
2024-10-26 @ 9:03 AM
Study NCT ID:
NCT00003694
Status:
COMPLETED
Last Update Posted:
2013-06-05
First Post:
1999-11-01
Brief Title:
Homoharringtonine Plus Low-Dose Cytarabine in Treating Patients With Newly Diagnosed Chronic Myelogenous Leukemia in Chronic Phase
Sponsor:
National Cancer Institute NCI
Organization:
National Cancer Institute NCI
Conditions & Keywords Data
Conditions:
| Name |
|---|
| Chronic Myelogenous Leukemia BCR-ABL1 Positive |
| Chronic Phase Chronic Myelogenous Leukemia |
Keywords: